Early cancer screening is a key factor that significantly increases the chances of complete recovery. However, traditional screening methods can sometimes be time-consuming or may not cover multiple types of cancer simultaneously.
The SPOT-MAS technology helps overcome these limitations by requiring only a single blood draw to analyze DNA from cancer cells circulating in the bloodstream. This allows for early and accurate cancer detection, enabling patients to become aware of their condition sooner and receive timely treatment.
In-depth Behind the Scenes! The Efficiency and Accuracy of SPOT-MAS Screening
SPOT-MAS is a Multi-Cancer Early Detection (MCED) screening technology with high accuracy. It can detect abnormalities in cancer cells from the early stages by analyzing genetic material (DNA) released from cancer cells in the bloodstream, known as ctDNA.
With SPOT-MAS’s unique technology, it can detect up to 10 types of cancer from a single blood draw, while accurately identifying the origin of the cancer in the body, including the lungs, liver, intestines, breasts, ovaries, pancreas, and other organs.
Besides helping detect diseases before symptoms appear, the test results provide valuable information for treatment planning and long-term health monitoring. It can indicate future risk trends and assist doctors in systematic follow-up planning.
Therefore, SPOT-MAS technology is a significant advancement in preventive medicine, making cancer screening more accessible, faster, and safer for people.
Advantages – Limitations of Cancer Screening with SPOT-MAS
Advantages of SPOT-MAS
- Simple and fast
Only one blood draw is needed, causing less pain compared to other tests that require surgery or tissue biopsy. - Can screen for multiple types of cancer simultaneously
Can screen for 5–10 types of cancer, such as liver, breast, lung, colon, stomach, ovary, pancreas, and endometrium cancers. - No anesthesia required, reducing the risks and pain associated with surgery.
- High accuracy
With a specificity of 95.9% and sensitivity of 78.1%, these reliable values help detect early-stage cancer, increasing the chances of successful treatment. - Fast results within 14–30 days (depending on the hospital), enabling immediate treatment planning and behavior modification to reduce risks.
Limitations of SPOT-MAS
- Cannot confirm cancer 100% because the test only assesses risk. Follow-up or additional tests are required for confirmation.
- Not suitable for patients who have been treated for cancer within the past 5 years, as results may be inaccurate.
- The test is relatively expensive compared to general screening methods and cannot replace other tests in all cases.
Preparation Before SPOT-MAS Test
Preparation for the SPOT-MAS test is quite simple since it only requires a single blood draw. There is no need for complicated preparation like some other tests. However, to ensure the most accurate results, the following recommendations are advised:
- Avoid heavy or fatty foods before the test
You may eat light meals as usual but should avoid very fatty or heavily fried foods on the day of the test to prevent blood from becoming too thick.
- Avoid alcohol and strong caffeine drinks
Avoid alcohol and reduce consumption of strong coffee or tea 24 hours before the test, as these may affect blood condition.
- Drink enough water
Drinking enough water helps make blood drawing easier and improves blood circulation.
- Inform your doctor about any medications you are taking
If you are taking certain medications, such as blood thinners or hormone drugs, inform your doctor before the blood draw.
- Get enough rest
Getting adequate sleep before the test helps keep your body in normal condition and ensures the best blood quality.
- Wear clothing convenient for blood drawing
Wear short sleeves or clothes that can be easily rolled up.
Therefore, SPOT-MAS is a modern, fast, and minimally invasive early cancer screening technology that can detect multiple types of cancer simultaneously. It is suitable for those seeking preventive health screening, especially individuals at high risk. However, the limitations should be considered with a doctor before testing to ensure the most accurate and appropriate results.
